Tag: Viruses
Decreases in Mpox Vaccination Shortfall Needed in Minorities
To achieve equitable progression in vaccination, decreases in shortfalls needed for Black, AI/AN persons
FDA Approves Pfizer RSV Vaccine for Older Adults
CDC expected to meet later in the month to adopt vaccine recommendations for older Americans
71 Percent of Mpox Cases Occurred in Large Central Urban Areas
In both rural and urban areas, incidence was consistently higher among Black and Hispanic versus White persons
More Mpox Cases Reported as Health Officials Fear a Summer Resurgence
U.S. cases are still at less than three per day, with 32 infections diagnosed in May so far
JYNNEOS Vaccine Seems Effective for Preventing Mpox
Two-dose series offers better protection, with vaccine effectiveness of 66.0 percent compared with 35.8 percent for one-dose
CDC Warns That Mpox Could Make a Summer Return
An outbreak in Chicago of the virus formerly called monkeypox has public health officials on edge
RSV in First Year of Life Tied to Risk for Childhood Asthma
Authors say association is age- and severity-dependent
WHO Declares Global Mpox Outbreak Over
WHO director-general cited a 90 percent drop in cases during the past three months
Uptick Seen in Mpox Cases in Chicago
Last week's case count was highest in Chicago since early November 2022 and highest weekly new case rate in any U.S. region so far this year
FDA Approves First RSV Vaccine
Arexvy was ~82 percent effective in preventing RSV-induced lower respiratory tract infections in adults 60 years of age and older
